Frontera Therapeutics (FRONT HK)

Frontera Therapeutics is a global, clinical-stage biotech company creating advanced AAV (adeno-associated virus) gene therapies for rare and common diseases, using their proprietary APEX platform for better vectors and a Suzhou GMP facility for low-cost, high-quality production.